Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2)

Genetic Testing

Volumn 12, Issue 4, 2008, Pages 523-532

  Juan, Anne S ^a,b   Wakefield, Claire ^a,b   Kasparian, Nadine A ^a,b   Kirk, Judy ^c   Tyler, Janet ^b   Tucker, Kathy ^b,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; DECISION MAKING; GENE MUTATION; GENETIC COUNSELING; GENETIC PROCEDURES; HUMAN; MALE; ONCOGENE; OVARY CANCER; PILOT STUDY; RISK BENEFIT ANALYSIS;

AGED; BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PILOT PROJECTS;

EID: 57749083314     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2008.0035     Document Type: Article

References (53)

1. Addis ME, Mahalik JR (2003) Men, masculinity, and the contexts of help seeking. Am Psychol, 58:5-14.
2. Agrawal A, Ayantunde A, Rampaul R, et al. (2007) Male breast cancer: a review of clinical management. Breast Cancer Res Treat, 103:11-21.
3. American Urological Association (2000) Prostate-specific antigen (PSA) best practice policy. Oncology, 14:267-286.
4. Australian Bureau of Statistics (2006) Australian social trends 2006. Australian Bureau of Statistics, Canberra.
5. Basham VM, Lipscombe JM, Ward JM, et al. (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res, 4(R2):1-5.
6. Bekker HL, Hewison J, Thornton JG (2003) Understanding why decision aids work: linking process with outcome. Patient Educ Couns, 50:323-329.
7. Bleiker EMA, Aaronson NK, Menko FH (1997) Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members. Patient Educ Couns, 32:107-116.
8. Bottorf JL, Ratner PA, Johnson JL, et al. (1998) Communicating cancer risk information: the challenges of uncertainty. Patient Educ Couns, 33:67-81.
9. Brooks L, Lennard F, Shenton A, et al. (2004) BRCA1/2 predictive testing: a study of uptake in two centres. Eur J Hum Genet, 12:654-662.
10. Cull A, Anderson EDC, Campbell S, et al. (1999) The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer, 79:501-508.
11. Cutuli B (2007) Strategies in treating male breast cancer. Expert Opin Pharmacother, 8:193-202.
12. d'Agincourt-Canning L, Baird P (2006) Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations. Crit Rev Oncol Hematol, 58:114-123.
13. Daly MB, Lerman CL, Ross E, et al. (1996) Gail model breast cancer risk components are poor predictors of risk perception and screening behaviour. Breast Cancer Res Treat, 41:59-70.
14. Daly PA, Nolan C, Green A, et al. (2003) Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol, 14:549-553.
15. Edwards S, Kote-Jarai Z, Meitz J, et al. (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet, 72:1-12.
16. Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet, 367:595-604.
17. Ford D, Easton DF, Stratton M, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet, 62:676-689.
18. Giordano S (2005) A review of the diagnosis and management of male breast cancer. Oncologist, 10:471-479.
19. Giordano SH, Cohen DS, Buzdar AU, et al. (2004) Breast carcinoma in men: a population-based study. Cancer, 101:51-57.
20. Goddard B, Pratte A, Dumont M, et al. (2007) Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling. Genet Test, 11:45-54.
21. Green J, Richards M, Murton F, et al. (1997) Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns, 6:45-60.
22. Hallowell N, Ardern-Jones A, Eeles R, et al. (2005a) Men's decision-making about predictive BRCA1/2 testing: the role of family. J Genet Couns, 14:207-217.
23. Hallowell N, Ardern-Jones A, Eeles R, et al. (2005b) Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet, 67:492-502.
24. Hallowell N, Ardern-Jones A, Eeles R, et al. (2006) Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health Illn, 28:969-988.
25. Hubner D (2006) Genetic testing and private insurance - a case of "selling one's body"? Med Health Care Philos, 9:43-55.
26. Kamila C, Jenny B, Per H, et al. (2007) How to treat male breast cancer. Breast, 16:147-154.
27. Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol, 22:735-742.
28. Liede A, Metcalfe K, Hanna D, et al. (2000) Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet, 67:1494-1504.
29. Lodder L, Frets PG, Trijsburg RW, et al. (2001a) Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet, 98:15-24.
30. Lodder L, Frets PG, Trijsburg RW, et al. (2001b) Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet, 9:492-500.
31. Lohan M (2007) How might we understand men's health better? Integrating explanations from critical studies on men and inequalities in health. Soc Sci Med, 65:493-504.
32. Luce MF (2005) Decision making as coping. Health Psychol, 24:S23-S28.
33. Lynch HT, Lemon SJ, Durham C, et al. (1997) A descriptive study of BRCA1 testing and reactions to disclosure of testing results. Cancer, 79:2219-2228.
34. McAllister MF, Evans DGR, Ormiston W, et al. (1998) Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet, 35:739-744.
35. Metcalfe KA, Liede A, Hoodfar E, et al. (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet, 37:866-874.
36. Mitra A, Bancroft E, Eeles R (2007) A review of targeted screening for prostate cancer: introducing the IMPACT Study. BJU Int, 99:1350-1355.
37. Moynihan C (2002) Men, women, gender and cancer. Eur J Cancer Care, 11:166-172.
38. National Breast and Ovarian Cancer Centre (2006) Breast cancer in men. Australia. http://www.breasthealth.com.au/men/. Date accessed: 4 January 2008.
39. O'Connor AM (1999) Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst, 25:67-80.
40. O'Connor AM (2006) Ottawa Decision Support Framework. Ottawa Health Research Institute, Canada. www.orhi.ca/decisionaid. Date accessed: 20 June 2007.
41. O'Connor AM, Elwyn G, Baratt A, et al., IPDAS (2005) Criteria for Judging the Quality of Patient Decision Aids. Ottawa Health Research Institute, Ottawa, pp 1-3.
42. O'Connor AM, Llewellyn-Thomas H, Stacey D (2005) International Patient Decision Aid Standards Collaboration Background Document. Ottawa Health Research Institute, Ottawa, pp 1-54.
43. O'Connor AM, Stacey D, Entwistle V, et al. (2006) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev, 1:1-100.
44. O'Connor AM, Tugwell P, Welles GA, et al. (1998) Randomized trial of a portable, self-administered decision aid for post-menopausal women considering long-term preventative hormone replacement therapy. Med Decis Making, 18:295-303.
45. Tai CT, Domchek S, Parmigiani G, et al. (2007) Breast cancer risks among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst, 99:1811-1814.
46. The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst, 91:1310-1316.
47. The Institute of Cancer Research (2007) IMPACT: targeted prostate cancer screening. United Kingdom. http://impact-study.co.uk/en/public/aboutimpact. Date accessed: 12 March 2008.
48. Urological Society of Australia and New Zealand (2007) Screening for prostate cancer. http://www.urosoc.org.au/consumer_health/index.jsp?a= 1126157831. Date accessed: 13 April 2007.
49. Wakefield CE, Meiser B, Homewood J, et al. (2007a) Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet Couns, 16:325-339.
50. Wakefield CE, Meiser B, Homewood J, et al. (2007b) A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat, 107:289-301.
51. Wang C, Bowen DJ, Kardia SL (2005) Research and practice opportunities at the intersection of health education, health behavior, and genomics. Health Educ Behav, 32:686-701.
52. Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev, 14:20-26.
53. Williams B, Iredale R, Brain K (2003) Experiences of men with breast cancer: an exploratory focus group study. Br J Cancer, 89:1834-1836.